It has emerged that AI firm Palantir contacted a UK health minister directly over WhatsApp to push for expanding its NHS access to GP records. The company argued that merging hospital data with GP data was "unarguable logic," trying to win the minister over on that basis. What stands out most is that this data access was being pursued not through the formal procurement process, but from a minister's personal phone.
What happened?
Palantir holds a £330 million contract with NHS England; under that deal, the Federated Data Platform (FDP) processes secondary care data to speed up hospital waiting times and discharge processes. GP data was explicitly excluded from this contract. This past February, the company sent WhatsApp messages to Health Minister Zubir Ahmed proposing that this boundary be lifted. Doctors say an expansion of this kind could undermine patient-doctor trust.
Why does it matter?
The real story here isn't that Palantir wanted GP data — it's the channel through which it sought it. Access to public health data normally passes through formal procurement, parliamentary oversight, and scrutiny from bodies like the National Data Guardian and the ICO. Here, the process ran in reverse: an understanding was sought first with the minister through a personal channel, turning institutional oversight into, at best, a formality to be dealt with afterward. The UK has paid a steep price for this kind of back-channel approach to health data policy before — the 2014 care.data program was shelved after public backlash over fears that data could be shared with third parties without patient consent. In 2017, the Royal Free NHS Trust's data-sharing arrangement with Google DeepMind was also criticized by the ICO for lacking an adequate legal basis. In both cases, the loss of trust stemmed not from technical failure but from a lack of transparency.
Palantir's profile heightens this sensitivity. The company was co-founded by Trump backer Peter Thiel and traces its roots to intelligence and border-security software, Gotham, and is also associated with the data infrastructure used in US immigration enforcement. For an intelligence-and-defense company to seek access to GP records — which hold some of the population's most intimate information, including mental health notes, reproductive health, and addiction history — cannot be read as a purely technical procurement matter.
Who does this affect, and how?
Through the FDP contract, Palantir is already embedded within the NHS's secondary care data infrastructure. If GP data were added, vendor dependency would make a qualitative leap: GP records are the most complete health record spanning an individual's entire life, and far more sensitive than hospital data.
| Layer | Current scope (FDP) | Proposed expansion |
|---|---|---|
| Data type | Hospital/secondary care records | GP/primary care records |
| Sensitivity | Case-based, departmental | Longitudinal, lifelong, intimate |
| Contract status | Explicit, subject to oversight | Out of scope, no formal approval |
| Risk | Data integration | Single-vendor lock-in |
Once pipelines built on the Foundry architecture deepen, switching to a different vendor down the line becomes technically and financially difficult. That gives Palantir leverage over price and terms at contract renewal time — precisely the outcome competitive procurement is meant to prevent.
What's next?
There are several things worth watching: whether the ICO and the National Data Guardian take a formal position on the matter, whether pressure from the British Medical Association (BMA) and GP organizations produces a concrete outcome, and how the scope will be defined when the FDP contract comes up for renewal. It's also worth tracking whether similar back-channel efforts have been attempted by other AI vendors; if this incident isn't an exception, it would mean that access to public health data is now being shaped not at the procurement table, but in ministers' personal messaging apps.
It's entirely possible that Palantir's software has shortened NHS waiting times. But a service working well doesn't legitimize how its access gets expanded. The problem here isn't the technology itself — it's that decisions about public health data are being pushed outside of transparent processes.
Yorumlar (0)
Henüz yorum yok. İlk yorumu sen yaz.
Yorum yapmak için Sinyal'i indir
Yorumlar Sinyal hesabıyla yapılır. Mobil uygulamada giriş yap, yorum bırak.